This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by LAHLOU, N. Articles by SCHOLLER, R. Search for Related Content PubMed PubMed Citation Articles by LAHLOU, N. Articles by SCHOLLER, R.

Gonadotropin and -Subunit Secretion During Long Term Pituitary Suppression by D-Trp⁶-Luteinizing Hormone-Releasing Hormone Microcapsules as Treatment of Precocious Puberty^*

Fondation de Recherche en Hormonologie (N.L., M.R., M.-C.F., R.S.), and Hôpital Saint Vincent de Paul (J.-L.C, J.E.T.) Paris, France
Hôpital Saint Charles (C.S.) Montpellier, France
Veterans Administration Medical Center and Tulane University School of Medicine (A. V.S.) New Orleans Louisiana 70112

Address all correspondence and requests for reprints to: Dr. N. Lahlou, Fondation de Recherche en Hormonologie, B.P. 110, 94268 Fresnes Cedex, France.

Short term treatment with GnRH agonists has been reported to increase plasma gonadotropin -subunit (Gn) levels while decreasing plasma immunoreactive LH (IR-LH) levels. In this study we examined the effect of D-Trp⁶-LHRH (LHRH-A) in microcapsules (60 µg/kg, im, every 28 days for 1 yr) in 13 girls suffering from precocious puberty. Plasma IRGn was measured by RIA; plasma IR-LH and IR-FSH were measured by both polyclonal RIAs and monoclonal immunoradiometric assays (IRMA). Before treatment, basal IR-LH and IR-FSH levels and peak responses to LHRH measured by both RIA and IRMA were similar, and the Gn response paralleled that of LH. After the first injection of LHRH-A, RIA LH levels were significantly higher than pretreatment levels until day 21, while IRMA LH levels transiently increased, but returned to pretreatment levels by day 7 and became lower thereafter (P < 0.005). Plasma IR-Gn levels increased from days 3–21 (P < 0.05). After 1.5 months of treatment, basal RIA LH levels remained detectable and not different from pretreatment levels; IRMA LH levels were very low. The mean RIA and IRMA LH responses to LHRH were decreased at 1.5 and 12 months (P < 0.01). Basal plasma RIA and IRMA FSH levels were similar during treatment (P > 0.05) and significantly lower than pretreatment values (P < 0.01). The mean RIA and IRMA FSH responses to LHRH decreased significantly at 1.5 months (P < 0.001). After 12 months, both RIA and IRMA FSH responses were increased, but IRMA values were significantly lower than RIA values. A sustained increase in basal Gn values occurred, but there was a tendency for the peak levels after LHRH treatment to decrease, becoming significantly lower than pretreatment peak levels after 1 yr. The chromatographic analysis on Sephadex G-100 of a pool of plasma samples collected during a LHRH test in three children treated for 6 months indicated that IR-Gn coeluted with [¹²⁵I]Gn. The large discrepancy between RIA and IRMA LH values suggests the secretion of unusual LH molecules which are recognized by RIA but not by IRMA. The sustained release of large amounts of IR-Gn indicates dissociated effects of LHRH-A on - and β-subunit secretion by the gonadotrophs. The sustained response of Gn to LHRH demonstrates that gonadotroph cell LHRH receptors are still responsive to LHRH during treatment with a LHRH agonist.

^* This work was supported in part by a grant from the Fondation Isabelle Decazes de Noüe (Geneva, Switzerland).

Received December 1, 1986.

This article has been cited by other articles:

				E. A. Eugster, W. Clarke, G. B. Kletter, P. A. Lee, E. K. Neely, E. O. Reiter, P. Saenger, D. Shulman, L. Silverman, L. Flood, et al. Efficacy and Safety of Histrelin Subdermal Implant in Children with Central Precocious Puberty: A Multicenter Trial J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1697 - 1704. [Abstract] [Full Text] [PDF]

				J. E. Horvath, A. M. Bajo, A. V. Schally, M. Kovacs, F. Herbert, and K. Groot Effects of long-term treatment with the luteinizing hormone-releasing hormone (LHRH) agonist Decapeptyl and the LHRH antagonist Cetrorelix on the levels of pituitary LHRH receptors and their mRNA expression in rats PNAS, November 12, 2002; 99(23): 15048 - 15053. [Abstract] [Full Text] [PDF]

				J.-C. Carel, N. Lahlou, O. Jaramillo, V. Montauban, C. Teinturier, M. Colle, C. Lucas, and J. L. Chaussain Treatment of Central Precocious Puberty by Subcutaneous Injections of Leuprorelin 3-Month Depot (11.25 mg) J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4111 - 4116. [Abstract] [Full Text] [PDF]

				I. Cedrin-Durnerin, J.-M. Bidart, P. Robert, J.-P. Wolf, M. Uzan, and J.-N. Hugues Consequences on gonadotrophin secretion of an early discontinuation of gonadotrophin-releasing hormone agonist administration in short-term protocol for in-vitro fertilization Hum. Reprod., May 1, 2000; 15(5): 1009 - 1014. [Abstract] [Full Text] [PDF]

				S. B. Seminara, M. Beranova, L. M. B. Oliveira, K. A. Martin, W. F. Crowley Jr., and J. E. Hall Successful Use of Pulsatile Gonadotropin-Releasing Hormone (GnRH) for Ovulation Induction and Pregnancy in a Patient with GnRH Receptor Mutations J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 556 - 562. [Abstract] [Full Text]

				F. J. Hayes, D. J. McNicholl, D. Schoenfeld, E. E. Marsh, and J. E. Hall Free {alpha}-Subunit Is Superior to Luteinizing Hormone as a Marker of Gonadotropin-Releasing Hormone Despite Desensitization at Fast Pulse Frequencies J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 1028 - 1036. [Abstract] [Full Text]

				H. B. Lavoie, K. A. Martin, A. E. Taylor, W. F. Crowley, and J. E. Hall Exaggerated Free {alpha}-Subunit Levels during Pulsatile Gonadotropin-Releasing Hormone Replacement in Women with Idiopathic Hypogonadotropic Hypogonadism J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 241 - 247. [Abstract] [Full Text]

				R. D. Clemons, M. S. Kappy, T. E. Stuart, A. H. Perelman, and F. T. Hoekstra Long-term Effectiveness of Depot Gonadotropin-Releasing Hormone Analogue in the Treatment of Children With Central Precocious Puberty Arch Pediatr Adolesc Med, June 1, 1993; 147(6): 653 - 657. [Abstract] [PDF]